ELYSE LAKE: Open Payments
NPI 1063721611 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 40 payments from 16 companies in 2025. Trend: 2023 $1,103 · 2024 $1,004 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $234 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $79 |
| Alkermes, Inc. | 3 | $74 |
| PFIZER INC. | 4 | $63 |
| Amgen Inc. | 3 | $48 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $36 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: BREZTRI, JARDIANCE, CAPLYTA, LYBALVI, NURTEC ODT, FARXIGA, OTEZLA, INSPIRE.
Industry payments across UT — which companies pay providers there.
